Opportunity ID: 328149

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-20-267
Funding Opportunity Title: NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 17, 2020
Last Updated Date: Jul 17, 2020
Original Closing Date for Applications: Nov 17, 2022
Current Closing Date for Applications: Nov 17, 2022
Archive Date: Dec 23, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
City or township governments
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
County governments
Private institutions of higher education
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
State governments
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing research and also to extend the focus of research to drug abuse and addiction. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are encouraged. An application should integrate and promote research in existing funded projects, to achieve new and creative directions. It is expected that individual core activities reflect a relationship to the integrating theme of the Center and the Center is expected to provide research opportunities and experiences to new investigators , and share findings, data and their resources, consistent with achieving the goals of the program.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-267.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 328149 Full Announcement-PAR-20-267 -> PAR-20-267-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00262613 Aug 25, 2020 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00269931 Oct 29, 2021 Nov 17, 2022 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277481 Oct 27, 2022 Nov 17, 2022 View

Package 1

Mandatory forms

328149 RR_SF424_2_0-2.0.pdf

328149 PHS398_CoverPageSupplement_5_0-5.0.pdf

328149 RR_OtherProjectInfo_1_4-1.4.pdf

328149 PerformanceSite_2_0-2.0.pdf

328149 RR_KeyPersonExpanded_2_0-2.0.pdf

328149 PHS398_ResearchPlan_4_0-4.0.pdf

328149 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

328149 PHS_Additional_IndirectCosts-1.0.pdf

328149 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

328149 RR_SF424_5_0-5.0.pdf

328149 PHS398_CoverPageSupplement_5_0-5.0.pdf

328149 RR_OtherProjectInfo_1_4-1.4.pdf

328149 PerformanceSite_4_0-4.0.pdf

328149 RR_KeyPersonExpanded_4_0-4.0.pdf

328149 PHS398_ResearchPlan_4_0-4.0.pdf

328149 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

328149 PHS_Additional_IndirectCosts_2_0-2.0.pdf

328149 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

328149 RR_SF424_5_0-5.0.pdf

328149 PHS398_CoverPageSupplement_5_0-5.0.pdf

328149 RR_OtherProjectInfo_1_4-1.4.pdf

328149 PerformanceSite_4_0-4.0.pdf

328149 RR_KeyPersonExpanded_4_0-4.0.pdf

328149 PHS398_ResearchPlan_5_0-5.0.pdf

328149 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

328149 PHS_Additional_IndirectCosts_2_0-2.0.pdf

328149 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-10T12:19:35-05:00

Share This Post, Choose Your Platform!

About the Author: